EpiVax Oncology's Seed Round

EpiVax Oncology raised a round of funding on September 25, 2017. Investors include EpiVax.

EpiVax Oncology (EO) is developing precision cancer immunotherapies based on Neo-Epitopes selected using proprietary and validated, in silico, predictive algorithms. Using genetic profiling (via NGS S…

Articles about EpiVax Oncology's Seed Round: